IOVS Clinical Microbiology Reviews
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Investigative Ophthalmology and Visual Science. 2007;48:2230-2237.)
© 2007 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.06-0954

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ghate, D.
Right arrow Articles by Edelhauser, H. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ghate, D.
Right arrow Articles by Edelhauser, H. F.

Pharmacokinetics of Intraocular Drug Delivery by Periocular Injections Using Ocular Fluorophotometry

Deepta Ghate, William Brooks, Bernard E. McCarey, and Henry F. Edelhauser

From the Emory University Eye Center, Atlanta, Georgia.

PURPOSE. To evaluate the pharmacokinetics of the periocular injections: posterior subtenon (PST), retrobulbar (RB), and subconjunctival (SC) injection.

METHODS. Two sodium fluorescein (NaF) concentrations, 2.5 mg in 0.1 mL (NaF1) and 2.5 mg in 0.5 mL (NaF2) were injected into live rabbits by the PST (NaF1 n = 4, NaF2 n = 3), RB (NaF1 n = 10), SC (NaF1 n = 6), and intravenous (IV, NaF1 n = 6) routes and into euthanatized rabbits by the RB (NaF1 n = 8) route. NaF concentrations in the choroid/retina, vitreous, and anterior segment were measured by ocular fluorophotometry. The NaF level in the contralateral choroid/retina was used as a measure of the systemic drug levels.

RESULTS. The maximum NaF concentrations (nanograms per milliliter) in the choroid/retina after PST, RB, SC, and IV were 757 ± 549 at 2 hours, 906 ± 1014 at 1 hour, 320 ± 462 at 2 hours, and 865 ± 363 at 5 to 10 minutes, respectively. The PST had the highest and most prolonged vitreous NaF1 concentration (maximum: 270 ± 226 ng/mL at 3.5 hours). The contralateral peak choroid/retina NaF levels after the RB, SC, and IV injections were 7, 4, and 21 times greater than after the PST injection. The SC injection had the highest anterior segment NaF concentration (5364 ± 2840 ng/mL at 2 hours). PST with NaF2 resulted in intraocular NaF levels higher than with NaF1.

CONCLUSIONS. NaF reaches the choroid/retina by transscleral diffusion from the periocular depot. The orbital and conjunctival vasculature and lymphatics have a larger role in NaF clearance than does the choroid. NaF diffuses into the vitreous from the choroid and the anterior segment; the periocular depot location determines the predominant diffusion pathway. The duration of high NaF levels in the choroid/retina or the anterior segment determines vitreous NaF levels. PST is the best periocular route for vitreous NaF delivery with minimal systemic levels. Increasing the volume of NaF PST depot enhances transscleral drug delivery.





This article has been cited by other articles:


Home page
IOVSHome page
S. J. Lee, E. S. Kim, D. H. Geroski, B. E. McCarey, and H. F. Edelhauser
Pharmacokinetics of Intraocular Drug Delivery of Oregon Green 488-Labeled Triamcinolone by Subtenon Injection Using Ocular Fluorophotometry in Rabbit Eyes
Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4506 - 4514.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
J. Y. Tsui, C. Dalgard, K. R. Van Quill, L. Lee, H. E. Grossniklaus, H. F. Edelhauser, and J. M. O'Brien
Subconjunctival Topotecan in Fibrin Sealant in the Treatment of Transgenic Murine Retinoblastoma
Invest. Ophthalmol. Vis. Sci., February 1, 2008; 49(2): 490 - 496.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
A. C. Amrite, H. F. Edelhauser, and U. B. Kompella
Modeling of Corneal and Retinal Pharmacokinetics after Periocular Drug Administration
Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 320 - 332.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the Association for Research in Vision and Ophthalmology